Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the need for extended follow-up after CAR T-cell therapy to obtain long term safety data. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.